{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:44:12Z","timestamp":1773236652637,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Adolescent Health"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jadohealth.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T16:16:28Z","timestamp":1345047388000},"page":"322-329","source":"Crossref","is-referenced-by-count":16,"title":["Clinical Trial Experience With Prophylactic Human Papillomavirus 6\/11\/16\/18 Vaccine in Young Black Women"],"prefix":"10.1016","volume":"52","author":[{"given":"Liana R.","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan R.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warner","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar A.","family":"Joura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Paavonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret K.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather L.","family":"Sings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred J.","family":"Saah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth I.O.","family":"Garner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jadohealth.2012.07.003_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"issue":"Suppl 3","key":"10.1016\/j.jadohealth.2012.07.003_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib6","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: Burden and management of non-cancerous HPV-Related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-Adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib8","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib10","doi-asserted-by":"crossref","first-page":"261.e1","DOI":"10.1016\/j.ajog.2007.09.001","article-title":"Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women","volume":"198","author":"Barr","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/ijc.23260","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women","volume":"122","author":"Perez","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1468-3083.2009.03266.x","article-title":"The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24","volume":"23","author":"Majewski","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijgo.2008.03.021","article-title":"Clinical trial experience with prophylactic HPV 6\/11\/16\/18 VLP vaccine in young women from the Asia-pacific region","volume":"102","author":"Tay","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/521679","article-title":"Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.107.704023","article-title":"Ethnic differences in cardiovascular drug response: Potential contribution of pharmacogenetics","volume":"118","author":"Johnson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib16","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.280.13.1168","article-title":"Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy","volume":"280","author":"Preston","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4158\/EP09285.OR","article-title":"Impact of race\/ethnicity on the efficacy and safety of commonly used insulin regimens: A post hoc analysis of clinical trials in type 2 diabetes mellitus","volume":"16","author":"Davidson","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/da.20568","article-title":"Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: Results of the NIMH STAR(*)D trial","volume":"26","author":"Friedman","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.genhosppsych.2005.07.002","article-title":"Treating minority patients with depression and anxiety: What does the evidence tell us?","volume":"28","author":"Schraufnagel","year":"2006","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/135965350801300507","article-title":"Factors influencing efavirenz and nevirapine plasma concentration: Effect of ethnicity, weight and co-medication","volume":"13","author":"St\u00f6hr","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.arcmed.2009.07.008","article-title":"Impact of a quadrivalent HPV6\/11\/16\/18 vaccine in Mexican women: Public health implications for the region","volume":"40","author":"Lazcano-Ponce","year":"2009","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/CVI.00478-06","article-title":"Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines","volume":"14","author":"Garland","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0272-2712(03)00053-2","article-title":"The Bethesda system 2001: An update of new terminology for gynecologic cytology","volume":"23","author":"Henry","year":"2003","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/AOG.0b013e3181c2ca21","article-title":"Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6\/11\/16\/18 vaccine: A combined analysis of five randomized controlled trials","volume":"114","author":"Garland","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/03610929808832160","article-title":"Exact power and sample size for vaccine efficacy studies","volume":"27","author":"Chan","year":"1998","journal-title":"Commun Stat Theory Methods"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib27","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1086\/522864","article-title":"Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection","volume":"196","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S0098858800002823","article-title":"The participation of underrepresented minorities in clinical research","volume":"29","author":"Noah","year":"2003","journal-title":"Am J Law Med"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib30","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: Race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jvs.2009.01.012","article-title":"Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials","volume":"50","author":"Hoel","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/003335490512000509","article-title":"Enrollment of racial\/ethnic minorities in NIAID-Funded networks of HIV vaccine trials in the United States, 1988 to 2002","volume":"120","author":"Djomand","year":"2005","journal-title":"Public Health Rep"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0027-9684(15)30833-6","article-title":"Exploring the \u201clegacy\u201d of the Tuskegee syphilis study: A follow-up study from the Tuskegee Legacy Project","volume":"101","author":"Katz","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/jwh.2007.0486","article-title":"Beliefs of women's risk as research subjects: A four-city study examining differences by sex and by race\/ethnicity","volume":"18","author":"Russell","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/107327480801500409","article-title":"Participation in biomedical research studies and cancer screenings: Perceptions of risks to minorities compared with whites","volume":"15","author":"Katz","year":"2008","journal-title":"Cancer Control"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0027-9684(15)31037-3","article-title":"Perceptions of pediatric clinical research among African American and Caucasian parents","volume":"101","author":"Shaw","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1525-1497.1999.07048.x","article-title":"Attitudes and beliefs of African Americans toward participation in medical research","volume":"14","author":"Corbie-Smith","year":"1999","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib38","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2010.02.019","article-title":"Post-licensure monitoring of HPV vaccine in the United States","volume":"28","author":"Markowitz","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2012.07.003_bib39","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1016\/j.vaccine.2010.04.070","article-title":"A summary of the post-licensure surveillance initiatives for GARDASIL\/SILGARD","volume":"28","author":"Bonanni","year":"2010","journal-title":"Vaccine"}],"container-title":["Journal of Adolescent Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054139X12002601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054139X12002601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T09:49:27Z","timestamp":1687686567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054139X12002601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1054139X12002601"],"URL":"https:\/\/doi.org\/10.1016\/j.jadohealth.2012.07.003","relation":{},"ISSN":["1054-139X"],"issn-type":[{"value":"1054-139X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}